The Valley Desk

Clinical trial reportDiabetes, obesity & metabolismPublished

No evidence of compensatory changes in energy balance, despite reductions in body weight and liver fat, during dapagliflozin treatment in type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled, cross-over trial (ENERGIZE)

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Clinical trial report
Venue
Diabetes, obesity & metabolism
Published
Subject terms
Liver; Humans; Diabetes Mellitus, Type 2; Body Weight; Benzhydryl Compounds; Glucosides; Blood Glucose; Hypoglycemic Agents; Treatment Outcome; Cross-Over Studies; Double-Blind Method; Energy Metabolism
PubMed ID
37667658
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal